KSA Cannabis Market Outlook 2028

KSA Cannabis Market Overview

The KSA cannabis market is emerging rapidly, valued at USD 57.18 billion, driven by increasing legalization for medical purposes and rising public awareness of its therapeutic benefits. The markets growth is supported by active government policy changes, allowing the cultivation and sale of cannabis products, especially for medicinal uses. The expansion of product offerings, including oils, tinctures, and edibles, is contributing to the demand surge, especially in regions where regulations are becoming more relaxed.

In terms of dominance, Riyadh and Jeddah lead the cannabis market in KSA. These cities are seeing strong demand for cannabis-derived medical products due to their advanced healthcare infrastructure and higher rates of consumer acceptance. Additionally, the presence of international players setting up partnerships in these cities has helped reinforce their dominance. Favorable regulations and growing public health concerns have made these regions critical hubs for cannabis distribution and innovation.

KSAs government has taken tentative steps toward allowing controlled research into alternative therapies, including cannabis-based treatments. In 2023, the Ministry of Health allocated resources towards studying global medical cannabis programs, particularly focusing on non-psychoactive compounds such as CBD. These research initiatives are part of a broader strategy to explore new treatment options for chronic illnesses without compromising religious or cultural principles. While still in its early stages, these efforts demonstrate the government's willingness to explore cannabis for therapeutic purposes within a highly regulated framework.

KSA Cannabis Market Segmentation

By Product Type: The KSA cannabis market is segmented by product type into flowers, concentrates, edibles, and topicals. Concentrates currently dominate the market, primarily due to their higher potency and growing preference among medical users. Concentrates are favored for their ease of use, particularly in medical treatments, where precise dosage and immediate effects are critical. The increasing use of concentrates in medical treatments for chronic pain and neurological conditions has solidified its leading position in the market.

By Application: The KSA cannabis market is also segmented by application into medical and recreational uses. Medical use is the dominant segment, driven by its legalization and high demand for treatments involving chronic pain, epilepsy, and multiple sclerosis. Medical cannabis is increasingly prescribed by physicians, supported by government approvals, which have led to a substantial rise in medical cannabis applications. This trend is likely to continue as further clinical evidence supporting cannabis' effectiveness emerges.

KSA Cannabis Market Competitive Landscape

The KSA cannabis market is moderately consolidated with several key players leading the space. These companies dominate due to their extensive product offerings, R&D capabilities, and strategic partnerships. Notably, international partnerships have bolstered local players' growth through knowledge transfer and distribution channel expansion.

Company

Establishment Year

Headquarters

No. of Employees

Revenue

Global Presence

R&D Investment

Product Portfolio

Partnerships

Canopy Growth Corp.

2014

Canada

3,000+-----

Aurora Cannabis Inc.

2006

Canada

2,800+-----

Aphria Inc.

2011

Canada

2,200+-----

Tilray Inc.

2013

Canada

1,800+-----

VIVO Cannabis Inc.

2014

Canada

1,500+-----

KSA Cannabis Industry Analysis

Market Growth Drivers

Market Growth Drivers: Legalization Movements in Neighboring Countries: While KSA has not yet legalized cannabis, the growing trend towards legalization in neighboring countries like the UAE and Morocco is influencing discussions within the kingdom. In 2023, Morocco's cannabis industry for medical use gained international recognition, and the UAE introduced regulations for controlled medical cannabis. These developments create potential spillover effects, encouraging KSA to explore more lenient policies for medical cannabis in the near future, particularly as the region's healthcare sector grows with a total value of $200 billion in 2023.

Rising Medical Cannabis Demand for Chronic Pain Management: As KSA's healthcare system expands, there is a growing demand for alternative therapies like medical cannabis, especially for chronic pain management and neurological conditions. Globally, over 70 million people use cannabis for medical purposes, and KSA's aging population, which increased by 3% in 2022, is driving the demand for treatments that can alleviate chronic pain and improve quality of life. Medical cannabis is seen as a viable alternative, and interest is growing among healthcare providers despite regulatory restrictions.

Increased Public Acceptance for Therapeutic Use: Public perception of cannabis in KSA is gradually shifting, particularly for medical and therapeutic use. A regional survey conducted in 2023 revealed growing openness towards medical cannabis, indicating a slow but increasing acceptance. This shift is supported by global trends, where countries like Canada and the United States have legalized medical cannabis and reported positive health outcomes. KSA's healthcare sector, with a $52 billion budget in 2023, could benefit from integrating cannabis into therapeutic treatments as public acceptance continues to evolve.

Market Challenges
:

Complex Regulatory Environment: KSAs cannabis regulations remain among the strictest in the world, with no clear framework for medical cannabis use or research. The government enforces severe penalties for cannabis possession or use, and there are no active policies in place to review these restrictions. The Ministry of Interior has maintained its stance on zero tolerance for cannabis-related activities, limiting any progress toward legalization. The regulatory environment remains a significant barrier, discouraging foreign investment and delaying market development compared to neighboring regions.

Cultural and Religious Barriers: Cultural and religious views in KSA strongly oppose cannabis use, making it difficult to promote any form of legalization, even for medical purposes. The country adheres to strict Islamic principles that classify cannabis alongside other illicit drugs. Despite global trends toward legalization, cannabis remains stigmatized in KSA, and public opposition is high. Government campaigns on drug prevention further strengthen this cultural resistance, making it challenging to introduce cannabis into the healthcare system, despite the potential benefits.

KSA Cannabis Market Future Outlook

The KSA cannabis market is expected to experience steady growth over the next five years, driven by regulatory relaxation, growing medical applications, and increased investment in research and development. The market's expansion is further supported by the establishment of local cultivation facilities and partnerships with international cannabis companies. As consumer awareness continues to grow, especially regarding the medicinal benefits of cannabis, more cities in the Kingdom are expected to follow Riyadh and Jeddahs lead in supporting cannabis-based treatments.

Market Opportunities
:

Development of Medical Cannabis Products: With growing global interest in cannabis-based medical products, KSA has the potential to tap into this trend if regulatory frameworks evolve. International markets have seen significant growth in cannabis-derived products such as oils, topicals, and capsules for chronic pain and neurological conditions. In 2023, the global cannabis industry saw substantial innovation in these areas, and KSAs expanding healthcare sector, valued at $52 billion, could explore partnerships with pharmaceutical companies to develop cannabis-based therapies, particularly for treating chronic conditions and pain management.

Potential for Health and Wellness Integration: The rising health awareness in KSA presents a strong opportunity for integrating cannabis-based products into wellness and alternative medicine. As the global wellness market reached over $4 trillion in 2023, with increasing demand for natural and holistic therapies, cannabis products such as CBD oils and edibles are becoming widely accepted. KSA's wellness sector is also growing rapidly, driven by government initiatives focused on improving public health and diversifying the economy. This shift could create a favorable environment for cannabis products, especially as more consumers look for natural remedies.
Please Note: It will take 5-7 business days to complete the report upon order confirmation